The closure of schools from 23 March 2020 interrupted the delivery of school-aged immunisation programmes, including human papillomavirus (HPV). NHS England and its commissioned school aged providers continue to implement the advice from the Joint Committee on Vaccination and Immunisation regarding HPV vaccinations. The National Health Service is therefore prioritising the first dose of HPV vaccine for all those eligible whilst working to recover those school aged immunisations which have been previously missed. The Department and NHS England are working closely with the Department for Education to ensure that schools facilitate the continuation of vaccinations and improving uptake rates for school-aged vaccinations.<\/p>
Providers are currently focussed on delivering the flu vaccine in schools, as is usual for this time of year, as well as the COVID-19 and expanded flu immunisation programme. School providers will recommence work on routine and outstanding vaccinations in the new year.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2021-11-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-11-17T17:24:07.47Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-11-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to progress the delivery of HPV vaccination, following the Minister's response to HC Deb, 25 March 2021, who stated that missed school aged vaccinations would be delivered no later than August 2021.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4370", "label" : {"_value" : "Biography information for Jess Phillips"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Yardley"} , "tablingMemberPrinted" : [{"_value" : "Jess Phillips"} ], "uin" : "73854"} , {"_about" : "http://data.parliament.uk/resources/1255023", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1255023/answer", "answerText" : {"_value" : "
NHS England and NHS Improvement are working closely with Public Health England and the Department to drive improvements in immunisation uptake and coverage in all routine childhood immunisations. The Department intends to publish a vaccination strategy in the near future to maintain and develop the United Kingdom\u2019s immunisation programme.<\/p>
<\/p>
The human papillomavirus (HPV) vaccination is routinely administered in schools, with a target of 90% coverage for 13 to 14 year old females. Where full HPV coverage has not been attained in schools, HPV vaccination can be administered in general practice up to the age of 25 to support high levels of population coverage. A review of vaccination and immunisations in 2019 has led to reformed general practice contractual arrangements to support the delivery of vaccination activity to increase coverage. In addition, all practices are required to have a named vaccination lead, to support maximisation of uptake.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2020-12-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1255023/answer/previousversion/65346", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} } , "questionFirstAnswered" : [{"_value" : "2020-12-10T16:42:01.907Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-11-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to commit to achieving 90 per cent HPV vaccination coverage by 2030 as set out in the World Health Organisation\u2019s Global Strategy to Accelerate the Elimination of Cervical Cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"} } , "tablingMemberConstituency" : {"_value" : "Central Ayrshire"} , "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"} ], "uin" : "120073"} , {"_about" : "http://data.parliament.uk/resources/1109798", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1109798/answer", "answerText" : {"_value" : "
The UK is supporting the increased use of the HPV vaccine through Gavi, the Vaccine Alliance. The UK is the largest donor to Gavi, which has helped 30 countries take the first steps to introducing the HPV vaccine with the aim of vaccinating 40 million girls by 2020. This will protect the poorest and most vulnerable girls from the leading cause of cervical cancer.<\/p>
UK support for Gavi is also helping accelerate the introduction of the HPV vaccine to more countries through Gavi\u2019s market shaping and price reduction strategy, which is making the vaccine more available and affordable.<\/p>
Civil society and young girls play a key role in ensuring the vaccine is accepted and in high demand. Gavi supports these groups through positive communications and messaging about the full benefits of the HPV vaccine and the protection it offers.<\/p>
The UK will host Gavi\u2019s next pledging conference in 2020, demonstrating our continued strong commitment to supporting Gavi's efforts to increase vaccinations against the HPV virus as well as other vaccine preventable diseases.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4107", "label" : {"_value" : "Biography information for Dame Harriett Baldwin"} } , "answeringMemberConstituency" : {"_value" : "West Worcestershire"} , "answeringMemberPrinted" : {"_value" : "Harriett Baldwin"} , "dateOfAnswer" : {"_value" : "2019-04-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-04-09T09:45:52.817Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2019-04-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, what steps his Department is taking to encourage the vaccination of women against the HPV virus in countries in which that vaccination is not yet available or accepted.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"} } , "tablingMemberConstituency" : {"_value" : "Coventry South"} , "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"} ], "uin" : "240947"} , {"_about" : "http://data.parliament.uk/resources/1022927", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1022927/answer", "answerText" : {"_value" : "
An evaluation of the first year (2016/17) of the pilot has been carried out. The following table shows the number of eligible men who have sex with men (MSM), up to age 45, who participated in the pilot human papillomavirus (HPV) vaccination programme available in sexual health clinics.<\/p>
<\/p>
MSM over the age of 45 years were not eligible for the HPV MSM vaccination pilot.<\/p>
<\/p>
The number of eligible MSM, up to age 45, participating in the HPV vaccination trial<\/p>
<\/p><\/td> | Under 25 years<\/p><\/td> | 26-30 years<\/p><\/td> | 31-35 years<\/p><\/td> | 36-40 years<\/p><\/td> | 41-45 years<\/p><\/td><\/tr> | ||||||||||||
Vaccinated with first dose<\/p><\/td> | 2,323<\/p><\/td> | 1,965<\/p><\/td> | 1,748<\/p><\/td> | 1,399<\/p><\/td> | 1,145<\/p><\/td><\/tr><\/tbody><\/table> <\/p>
|